Entrada Therapeutics Inc.

11.58
-0.36 (-3.02%)
At close: Mar 03, 2025, 12:41 PM

Entrada Therapeutics Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for TRDA stock have an median target of 28, with a low estimate of 20 and a high estimate of 29. The median target predicts an increase of 141.80% from the current stock price of 11.58.

Target Low Average Median High
Price $20 $25.67 $28 $29
Change 72.71% 121.68% 141.80% 150.43%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Entr... Unlock content with Pro Subscription

Updated Feb 25, 2025

Rating Mar 24Jun 24Aug 24Nov 24Dec 24Feb 25
Strong Buy 000100
Buy 112112
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 2 2 1 2

Financial Forecast this Year

Revenue This Year
43.24M
from 210.78M
Increased by -79.5%
Revenue Next Year
47.86M
from 43.24M
Increased by 10.7%
EPS This Year
-3.13
from 1.76
Increased by -77.8%
EPS Next Year
-3.28
from -3.13
Increased by -4.8%